Product Details
| Product Name:
ERD03 |
CAS No.:
1377897-01-2 |
| Purity:
99.47% |
Supply Ability:
10g |
| Release date:
2025/12/05 |
Product Introduction
Bioactivity
| Name | ERD03 |
| Description | ERD03 is a selective compound targeting EXOSC3, disrupting EXOSC3-RNA interactions in a concentration-dependent manner, useful in brain neurodegenerative disease research. |
| In vitro | Methods: ERD03 (50 μM) was incubated with EXOSC3 and several concentrations of long G-rich RNA. The effect of ERD03 on the RNA/EXOSC3 interaction was tested using MST to measure the inhibitory effect of ERD03.
Results: ERD03 reduced the binding of EXOSC3 to long G-rich RNA at several RNA concentrations; at 3.1 μM RNA, ERD03 inhibited the binding by 54%, in a concentration-dependent manner and similar inhibition was observed with long G-rich RNA. [1] |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 80 mg/mL (235.69 mM), Sonication is recommended.
|
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:1071173-56-2
$789.00 / 10mg
-
CAS:150-13-0
$29.00 / 1mL
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |